ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

ZTS vs GMAB // FREE CASH FLOW YIELD

Zoetis Inc. (NYSE) VS. Genmab A/S ADS (NASDAQ) • 15-METRIC TALLY: ZTS 7 — GMAB 5
▲ FREE CASH FLOW YIELD LEADER: ZTS
fcf-yield
7.01%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ZTS VS. GMAB) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC ZTS GMAB SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 71.80% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 25.70% 9.90% +15.80 ZTS /roic <GO>
EV/EBITDA & P/E Valuation 10.3x 21.0x -10.70 ZTS /valuation <GO>
Free Cash Flow Yield ACTIVE 7.01% 2.21% +4.80 ZTS /fcf-yield <GO>
Operating Margin 34.40% 13.90% +20.50 ZTS /operating-margins <GO>
Net Profit Margin 28.20% 10.90% +17.30 ZTS /net-margins <GO>
Revenue Growth (YoY) 2.30% 22.00% -19.70 GMAB /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 4.53 3.74 +0.79 ZTS /balance-sheet <GO>
Piotroski F-Score Quality 7/9 8/9 -1.00 GMAB /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 56.6 85.2 -28.60 GMAB /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 0.99 1.09 -0.10 GMAB /macro-sensitivity <GO>
Forward P/E Multiple 11.3x 27.6x -16.30 ZTS /forward-pe <GO>
Enterprise Scale & Market Cap $32.56B $35.25B -$2.69B GMAB /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR ZTS REV GMAB REV ZTS GROSS % GMAB GROSS % ZTS FCF GMAB FCF
FY 2025 $9.47B — 71.8% — $2.28B —
FY 2024 $9.26B — 70.6% — $2.30B —
FY 2023 $8.54B — — — $1.97B —
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ZTS // BETA 0.99
GMAB // BETA 1.09